138 related articles for article (PubMed ID: 15509663)
1. Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes.
Kemp DC; Zamek-Gliszczynski MJ; Brouwer KL
Toxicol Sci; 2005 Feb; 83(2):207-14. PubMed ID: 15509663
[TBL] [Abstract][Full Text] [Related]
2. Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes.
Marion TL; Perry CH; St Claire RL; Yue W; Brouwer KL
Toxicol Sci; 2011 Apr; 120(2):371-80. PubMed ID: 21262925
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity.
Leslie EM; Watkins PB; Kim RB; Brouwer KL
J Pharmacol Exp Ther; 2007 Jun; 321(3):1170-8. PubMed ID: 17374746
[TBL] [Abstract][Full Text] [Related]
4. Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes.
McRae MP; Lowe CM; Tian X; Bourdet DL; Ho RH; Leake BF; Kim RB; Brouwer KL; Kashuba AD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1068-75. PubMed ID: 16720753
[TBL] [Abstract][Full Text] [Related]
5. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Funk C; Ponelle C; Scheuermann G; Pantze M
Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
[TBL] [Abstract][Full Text] [Related]
6. Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport.
Bi YA; Kazolias D; Duignan DB
Drug Metab Dispos; 2006 Sep; 34(9):1658-65. PubMed ID: 16782767
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the transport properties of organic anion transporting polypeptide 1 (oatp1) and Na(+)/taurocholate cotransporting polypeptide (Ntcp): comparative studies on the inhibitory effect of their possible substrates in hepatocytes and cDNA-transfected COS-7 cells.
Kouzuki H; Suzuki H; Stieger B; Meier PJ; Sugiyama Y
J Pharmacol Exp Ther; 2000 Feb; 292(2):505-11. PubMed ID: 10640286
[TBL] [Abstract][Full Text] [Related]
8. Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury.
Yang K; Pfeifer ND; Köck K; Brouwer KL
J Pharmacol Exp Ther; 2015 May; 353(2):415-23. PubMed ID: 25711339
[TBL] [Abstract][Full Text] [Related]
9. Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition.
De Bruyn T; Sempels W; Snoeys J; Holmstock N; Chatterjee S; Stieger B; Augustijns P; Hofkens J; Mizuno H; Annaert P
J Pharm Sci; 2014 Jun; 103(6):1872-81. PubMed ID: 24652646
[TBL] [Abstract][Full Text] [Related]
10. Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport.
Wolf KK; Vora S; Webster LO; Generaux GT; Polli JW; Brouwer KL
Toxicol In Vitro; 2010 Feb; 24(1):297-309. PubMed ID: 19706322
[TBL] [Abstract][Full Text] [Related]
11. Effect of thiazolidinediones on bile acid transport in rat liver.
Snow KL; Moseley RH
Life Sci; 2007 Jan; 80(8):732-40. PubMed ID: 17126857
[TBL] [Abstract][Full Text] [Related]
12. Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human.
Jemnitz K; Veres Z; Vereczkey L
Toxicol Sci; 2010 May; 115(1):80-8. PubMed ID: 20147439
[TBL] [Abstract][Full Text] [Related]
13. Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes.
Marion TL; Perry CH; St Claire RL; Brouwer KL
Toxicol Appl Pharmacol; 2012 May; 261(1):1-9. PubMed ID: 22342602
[TBL] [Abstract][Full Text] [Related]
14. An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes.
Ansede JH; Smith WR; Perry CH; St Claire RL; Brouwer KR
Drug Metab Dispos; 2010 Feb; 38(2):276-80. PubMed ID: 19910518
[TBL] [Abstract][Full Text] [Related]
15. Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytes.
Guo C; He L; Yao D; A J; Cao B; Ren J; Wang G; Pan G
Toxicol Lett; 2014 Jan; 224(1):93-100. PubMed ID: 24120425
[TBL] [Abstract][Full Text] [Related]
16. Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytes.
Lee JK; Paine MF; Brouwer KL
J Pharmacol Exp Ther; 2010 Aug; 334(2):410-8. PubMed ID: 20430841
[TBL] [Abstract][Full Text] [Related]
17. In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.
Yanni SB; Augustijns PF; Benjamin DK; Brouwer KL; Thakker DR; Annaert PP
Drug Metab Dispos; 2010 Oct; 38(10):1848-56. PubMed ID: 20606004
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation.
Lee JK; Marion TL; Abe K; Lim C; Pollock GM; Brouwer KL
J Pharmacol Exp Ther; 2010 Jan; 332(1):26-34. PubMed ID: 19801447
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytochalasin D and colchicine on the uptake, translocation, and biliary secretion of horseradish peroxidase and [14C]sodium taurocholate in the rat.
Kacich RL; Renston RH; Jones AL
Gastroenterology; 1983 Aug; 85(2):385-94. PubMed ID: 6683208
[TBL] [Abstract][Full Text] [Related]
20. Biliary excretion of bile acids and organic anions in rats with dichloroethylene-induced bile canalicular injury.
Marumo T; Fukusato T; Takikawa H
J Gastroenterol; 2004 Oct; 39(10):981-7. PubMed ID: 15549452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
